Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Goedecke

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Clinical Pharmacology and Therapeutics|July 12, 2024
Limitations Reported in Evaluating Effectiveness of Risk Minimization Measures in the EU during 2018-2021: A Qualitative Analysis of Industry-Sponsored Post-Authorization Safety StudiesRenske J Grupstra, Thomas Goedecke, Helga Gardarsdottir
British Journal of Clinical Pharmacology|July 5, 2018
Response to 'Comment on 'Measuring the impact of medicines regulatory interventions - systematic review and methodological considerations' by Goedecke et al.'Thomas Goedecke, Daniel R Morales, Alexandra Pacurariu, et al.
Drug Safety|July 21, 2018
Correction to: Medication Errors: A Characterisation of Spontaneously Reported Cases in EudraVigilanceVictoria Newbould, Steven Le Meur, Thomas Goedecke, et al.
Drug Safety|July 13, 2017
Medication Errors: A Characterisation of Spontaneously Reported Cases in EudraVigilanceVictoria Newbould, Steven Le Meur, Thomas Goedecke, et al.
British Journal of Clinical Pharmacology|November 7, 2017
Measuring the impact of medicines regulatory interventions - Systematic review and methodological considerationsThomas Goedecke, Daniel R Morales, Alexandra Pacurariu, et al.
Drug Safety|November 9, 2017
Correction to: Medication Errors: A Characterisation of Spontaneously Reported Cases in EudraVigilanceVictoria Newbould, Steven Le Meur, Thomas Goedecke, et al.
Drug Safety|March 5, 2016
Medication Errors: New EU Good Practice Guide on Risk Minimisation and Error PreventionThomas Goedecke, Kathryn Ord, Victoria Newbould, et al.
Clinical Pharmacology and Therapeutics|August 27, 2023
Review of Studies Evaluating Effectiveness of Risk Minimization Measures Assessed by the European Medicines Agency Between 2016 and 2021Renske J Grupstra, Thomas Goedecke, Jet Scheffers, et al.
Pharmacoepidemiology and Drug Safety|March 7, 2019
The ENCePP Code of Conduct: A best practise for scientific independence and transparency in noninterventional postauthorisation studiesRosa Gini, Xavier Fournie, Helen Dolk, et al.
BMJ Open|September 7, 2018
Electronic healthcare databases in Europe: descriptive analysis of characteristics and potential for use in medicines regulationAlexandra Pacurariu, Kelly Plueschke, Patricia McGettigan, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinical Pharmacology and Therapeutics|July 12, 2024
Limitations Reported in Evaluating Effectiveness of Risk Minimization Measures in the EU during 2018-2021: A Qualitative Analysis of Industry-Sponsored Post-Authorization Safety StudiesRenske J Grupstra, Thomas Goedecke, Helga Gardarsdottir
British Journal of Clinical Pharmacology|July 5, 2018
Response to 'Comment on 'Measuring the impact of medicines regulatory interventions - systematic review and methodological considerations' by Goedecke et al.'Thomas Goedecke, Daniel R Morales, Alexandra Pacurariu, et al.
Drug Safety|July 21, 2018
Correction to: Medication Errors: A Characterisation of Spontaneously Reported Cases in EudraVigilanceVictoria Newbould, Steven Le Meur, Thomas Goedecke, et al.
Drug Safety|July 13, 2017
Medication Errors: A Characterisation of Spontaneously Reported Cases in EudraVigilanceVictoria Newbould, Steven Le Meur, Thomas Goedecke, et al.
British Journal of Clinical Pharmacology|November 7, 2017
Measuring the impact of medicines regulatory interventions - Systematic review and methodological considerationsThomas Goedecke, Daniel R Morales, Alexandra Pacurariu, et al.
Drug Safety|November 9, 2017
Correction to: Medication Errors: A Characterisation of Spontaneously Reported Cases in EudraVigilanceVictoria Newbould, Steven Le Meur, Thomas Goedecke, et al.
Drug Safety|March 5, 2016
Medication Errors: New EU Good Practice Guide on Risk Minimisation and Error PreventionThomas Goedecke, Kathryn Ord, Victoria Newbould, et al.
Clinical Pharmacology and Therapeutics|August 27, 2023
Review of Studies Evaluating Effectiveness of Risk Minimization Measures Assessed by the European Medicines Agency Between 2016 and 2021Renske J Grupstra, Thomas Goedecke, Jet Scheffers, et al.
Pharmacoepidemiology and Drug Safety|March 7, 2019
The ENCePP Code of Conduct: A best practise for scientific independence and transparency in noninterventional postauthorisation studiesRosa Gini, Xavier Fournie, Helen Dolk, et al.
BMJ Open|September 7, 2018
Electronic healthcare databases in Europe: descriptive analysis of characteristics and potential for use in medicines regulationAlexandra Pacurariu, Kelly Plueschke, Patricia McGettigan, et al.
Pageof 2